Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters
- PMID: 10438353
- DOI: 10.1086/314967
Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters
Abstract
Cross-sectional studies have demonstrated lower plasma human immunodeficiency virus type 1 (HIV-1) RNA virus levels (VLs) in women than in men, but it is unknown whether this sex difference is present at the time of seroconversion and throughout the course of infection. A nested case-control study was performed among HIV-1 seroconverters within a cohort of injection drug users. Plasma VL was determined longitudinally among both rapid progressors to AIDS (24 patients) and nonprogressors (47 controls). The initial median VL among female patients (n=10) was 14,918 copies/mL, compared with 148,354 copies/mL among male patients (n=14; P=.001); median plasma VL also tended to be lower among female (n=10) than among male controls (n=37; 11,917 vs. 61,311 copies/mL; P=.08). VL increased more rapidly over time in women than in men and subsequently converged in patients and controls, respectively. Understanding the mechanisms responsible for the sex difference in VL may provide insight into HIV-1 pathogenesis.
Similar articles
-
Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load.J Infect Dis. 1999 Oct;180(4):1018-24. doi: 10.1086/314980. J Infect Dis. 1999. PMID: 10479126
-
Plasma human immunodeficiency virus (HIV) type 1 RNA load in men and women with advanced HIV-1 disease.J Infect Dis. 2000 Aug;182(2):603-6. doi: 10.1086/315710. Epub 2000 Jul 21. J Infect Dis. 2000. PMID: 10915096
-
Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.J Infect Dis. 2001 Jan 1;183(1):23-35. doi: 10.1086/317658. Epub 2000 Dec 8. J Infect Dis. 2001. PMID: 11106536
-
Molecular biological assessment methods and understanding the course of the HIV infection.APMIS Suppl. 2003;(114):1-37. APMIS Suppl. 2003. PMID: 14626050 Review.
-
Infection with human immunodeficiency virus type-1. Seroconversion chronic infection and the development of AIDS.Dan Med Bull. 1994 Feb;41(1):12-22. Dan Med Bull. 1994. PMID: 8187563 Review. No abstract available.
Cited by
-
The impact of sex on HIV immunopathogenesis and therapeutic interventions.J Clin Invest. 2024 Sep 17;134(18):e180075. doi: 10.1172/JCI180075. J Clin Invest. 2024. PMID: 39286972 Free PMC article. Review.
-
Longitudinal patterns in indeterminate HIV rapid antibody test results: a population-based, prospective cohort study.Microbiol Spectr. 2024 Feb 6;12(2):e0325323. doi: 10.1128/spectrum.03253-23. Epub 2024 Jan 8. Microbiol Spectr. 2024. PMID: 38189332 Free PMC article.
-
Sex Differences in HIV Infection.Curr Top Microbiol Immunol. 2023;441:61-73. doi: 10.1007/978-3-031-35139-6_3. Curr Top Microbiol Immunol. 2023. PMID: 37695425
-
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial.Clin Infect Dis. 2022 Oct 12;75(8):1389-1396. doi: 10.1093/cid/ciac136. Clin Infect Dis. 2022. PMID: 35176755 Free PMC article. Clinical Trial.
-
HIV Viral Suppression among People Living with HIV on Antiretroviral Therapy in Haut-Katanga and Kinshasa Provinces of Democratic Republic of Congo.Healthcare (Basel). 2021 Dec 31;10(1):69. doi: 10.3390/healthcare10010069. Healthcare (Basel). 2021. PMID: 35052234 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical